Can Pre-IVF Tests in Hong Kong Be Done in Mainland China? Test Items and Process Explained
Pre-IVF tests in Hong Kong can be completed at top-tier hospitals in Mainland China, provided conditions such as consistent test items, mutual recognition of results, and validity periods are met. This article details which tests can be done in Mainland China, which must be done in Hong Kong, the process, and important considerations.
Document Type Identifier
Yes. Most of the pre-IVF tests in Hong Kong can be completed at qualified tertiary Grade A hospitals in Mainland China, but you need to confirm the test item list, report format, and mutual recognition requirements with the target Hong Kong fertility center in advance to ensure the results are accepted and within the validity period.
There are certain differences in test items and standards between the Hong Kong and Mainland China medical systems, so not all Mainland China test reports will be directly accepted by Hong Kong fertility centers. Properly planning the test path can save time and costs while avoiding delays in the cycle due to unrecognized results.
1. Which pre-tests can be done in Mainland China? Which must be done in Hong Kong?
According to the current requirements of Hong Kong fertility centers, pre-tests can be divided into three categories:
| Category | Test Items | Notes |
|---|---|---|
| ✅ Can be done in Mainland China | AMH, Sex Hormone Panel (FSH, LH, E2, etc.), Thyroid Function, Infectious Disease Screening (Hepatitis B, Hepatitis C, Syphilis, HIV), Complete Blood Count, Coagulation Function, Liver and Kidney Function, Urinalysis, Semen Analysis, Chromosome Karyotype, Blood Type, TORCH Panel, Vaginal Discharge Examination | Must be done at a tertiary Grade A hospital, reports must be stamped with the hospital seal; some centers require English or Traditional Chinese versions |
| ⚠️ Partially can be done in Mainland China | Antral Follicle Count (AFC), Sonohysterography, Breast Ultrasound, Thyroid Ultrasound | Need to confirm if the Hong Kong center accepts Mainland China ultrasound reports; some centers require operation by designated doctors |
| ❌ Usually need to be done in Hong Kong | Hysteroscopy, Endometrial Biopsy, Genetic Counseling (some centers), Specialized Male Sperm Function Tests (e.g., Sperm DNA Fragmentation, Acrosome Reaction) | Due to differences in operating standards, equipment, and legal liability, most Hong Kong centers require these to be done at their own facility or designated partner institutions |
2. Why is there a question about "whether tests can be done in Mainland China"?
There are three main differences between the Hong Kong and Mainland China medical systems in the field of assisted reproduction, leading to patient confusion about test mutual recognition:
- Standard Differences: Hong Kong fertility centers often refer to ESHRE (European Society of Human Reproduction and Embryology) or ASRM (American Society for Reproductive Medicine) standards, and some test items and reference ranges differ from those in Mainland China. For example, different brands of AMH test reagents may lead to result discrepancies.
- Validity Requirements: Hong Kong centers have strict validity periods for tests (usually 6 months), while items like chromosomes and blood type that do not change can be used long-term. Patients unaware of validity periods may end up with "invalid tests."
- Liability and Certification: Hong Kong medical institutions are legally responsible for test results, so they require certification for the laboratories issuing reports (e.g., ISO 15189). Although some Mainland China hospitals are tertiary Grade A, not all their laboratories hold certifications recognized by Hong Kong.
These objective differences make "whether tests can be mutually recognized" a key issue that needs to be confirmed in advance, rather than a simple yes or no.
3. 5 most easily overlooked details
According to practitioner observations, the following details are most often overlooked by patients, leading to test results being rejected or requiring re-testing:
- Report Language Version: Hong Kong centers usually accept Chinese or English reports, but some centers require key items (e.g., AMH, Chromosomes) to be provided in English. When Mainland China hospitals issue reports in pure Chinese, ask in advance if an English version can be added.
- Consistency of Test Item Names: The same test may have different names in Mainland China and Hong Kong. For example, "Anti-Müllerian Hormone (AMH)" is often referred to by its full Chinese name in Mainland China, while Hong Kong commonly uses "Anti-Müllerian Hormone" or "AMH." Ensure the item name can be correctly identified.
- Document Preparation: A valid Hong Kong Macau Travel Permit and visa are required for traveling to Hong Kong for the IVF cycle. Some centers require the document's validity to cover the entire cycle (recommended 6 months or more), planned in sync with the test result validity period.
- Chromosome Test Time Window: Chromosome karyotype analysis results usually take 10-14 working days, and some abnormal results require genetic counseling. It is recommended to complete this 2 months before starting the cycle to allow sufficient time for interpretation and decision-making.
- Male Tests Easily Overlooked: Semen analysis reference standards vary significantly by region. Hong Kong centers mostly adopt the WHO Sixth Edition standards. The format and parameters of Mainland China reports may not be directly accepted; confirm in advance whether re-testing is needed.
4. Actual Process: From Mainland China Tests to Hong Kong Cycle
The following is the standard operating path for patients planning IVF in Hong Kong:
| Step | Specific Content | Notes |
|---|---|---|
| 1 | Select a Hong Kong fertility center and complete an initial consultation (online or via coordinator) | Obtain the official test checklist and mutual recognition requirements |
| 2 | Take the checklist to the corresponding department at a tertiary Grade A hospital in Mainland China to request tests | Inform the doctor that Chinese/English reports are needed and must be stamped with the hospital seal |
| 3 | After obtaining reports, scan and send them to the Hong Kong center for pre-review | Pre-review can identify if supplementary or re-testing is needed in advance |
| 4 | After pre-review approval, bring the originals to Hong Kong for registration | Some centers require originals to have a hospital cross-page seal |
| 5 | Complete remaining mandatory tests in Hong Kong (e.g., hysteroscopy, genetic counseling) | Schedule appointments according to the center's arrangements |
| 6 | Once all tests are complete, proceed to cycle initiation | Pay attention to test validity periods to avoid expiration |
5. Timing: When is the best time to do the tests?
Different tests have different validity periods. Proper timing can reduce duplicate testing:
- Chromosome Karyotype, Blood Type: Valid for life; can be completed 3-6 months in advance without worrying about expiration.
- AMH, Sex Hormone Panel, Thyroid Function: Recommended to be completed 1-3 months before starting the cycle; valid for 6 months.
- Infectious Disease Screening (Hepatitis B, Hepatitis C, Syphilis, HIV): Valid for 6 months; recommended to be completed 1-2 months before traveling to Hong Kong.
- Semen Analysis: Valid for 3-6 months; some centers require within 3 months. Recommended to be completed 2 months before cycle initiation to allow for re-testing if necessary.
- Hysteroscopy: Valid for 6-12 months; recommended to be completed within 3 months before cycle initiation.
6. Frequently Asked Questions
7. Doctor's Perspective: How are Mainland China test results viewed?
From a clinical reproductive medicine perspective, doctors adopt a "cautious acceptance" attitude towards Mainland China test results. This is mainly based on the following considerations:
- Reference Range Differences: The reference range for the same item may differ between laboratories. For example, normal AMH values can vary with different reagent kits. Doctors need to combine specific values with clinical context for comprehensive judgment.
- Quality Control Standards: Hong Kong laboratories generally participate in international external quality assessment schemes (e.g., UK NEQAS), while the quality control level of different hospitals in Mainland China varies. Doctors trust reports from certified laboratories more.
- Clinical Decision Dependence: Some key indicators (e.g., FSH, AMH, Antral Follicle Count) directly influence the choice of ovulation induction protocol. If test results are biased, it may lead to protocol errors. Therefore, doctors have high accuracy requirements for these indicators.
8. Interpretation of Key Test Indicators
The following indicators are the most important in Hong Kong pre-IVF assessment. Understanding them in advance helps communication with the doctor:
| Indicator | Reference Range (General Reference) | Clinical Significance |
|---|---|---|
| AMH | 1.0-4.0 ng/mL (decreases with age) | Assesses ovarian reserve; AMH <1.0 indicates reduced reserve, <0.5 indicates severely reduced reserve |
| FSH | 3.0-10.0 IU/L (baseline, day 2-3 of menstrual cycle) | Elevated FSH (>10) suggests diminished ovarian reserve, affecting response to ovulation induction |
| LH | 2.0-8.0 IU/L (baseline) | Abnormal LH/FSH ratio may indicate Polycystic Ovary Syndrome (PCOS) or ovarian dysfunction |
| E2 | 25-75 pg/mL (baseline) | High baseline E2 may indicate premature follicle development or ovarian cyst |
| Antral Follicle Count (AFC) | 5-10 per ovary (baseline antral follicles) | Directly reflects ovarian reserve; total AFC <5-7 indicates reduced reserve |
| Sperm Concentration | ≥16 × 10⁶ /mL (WHO Sixth Edition) | Below reference indicates oligospermia, affecting choice of fertilization method |
The above reference ranges are for general reference only. Please refer to the laboratory standards adopted by the Hong Kong fertility center.
9. 4 most common pitfalls
- Getting tests without prior communication: Conducting tests without obtaining the Hong Kong center's checklist results in incomplete or unrecognized items, requiring re-testing. This is the most common mistake.
- Ignoring report validity: Delaying travel to Hong Kong after tests for various reasons leads to expired results. It is recommended to arrange tests after confirming the cycle start date, or choose items with longer validity periods first.
- Not expediting chromosome report: Chromosome karyotype analysis requires cell culture, usually taking 10-14 days. Some patients underestimate the waiting time, causing overall progress delays.
- Assuming all tertiary Grade A hospitals are acceptable: Not all tertiary Grade A hospital laboratories have quality control certifications recognized by Hong Kong. It is recommended to choose large comprehensive tertiary Grade A hospitals or provincial maternal and child health hospitals, as their laboratories are more likely to have ISO 15189 certification.
10. Special Situation Handling
Situation 1: Low AMH value (<1.0 ng/mL)
If a low AMH is found in Mainland China, it is recommended to re-test after arriving in Hong Kong for confirmation. Because results may differ between different reagent kits, and doctors need to combine AFC, FSH, and other indicators for comprehensive judgment. If reduced reserve is confirmed, enter the cycle as soon as possible to avoid further decline due to waiting.
Situation 2: Abnormal chromosome results
If the chromosome karyotype reveals abnormalities (e.g., balanced translocation, inversion), genetic counseling is needed to assess the impact on the IVF protocol (whether PGT is needed). Such counseling usually needs to be completed at the Hong Kong fertility center or a designated genetic counseling institution; Mainland China reports can be used as reference.
Situation 3: Fluctuating semen analysis results
Semen quality is affected by various factors such as abstinence time, recent health status, and collection method. If the Mainland China report shows abnormalities, it is recommended to re-test 2-3 times in Hong Kong (with intervals of 2-4 weeks) to obtain stable baseline data.
Medical Editor · Reproductive Medicine Knowledge Base | Content Review: Assisted Reproduction Industry Researcher | Update Date: 2025
0 comments